S. 2398 would reauthorize the appropriation of the following amounts to the Department of Health and Human Services for each year between 2026 to 2030:
$10 million for awarding grants, contracts, or cooperative agreements to support regional centers of excellence that address vector-borne diseases, and
$20 million for entering into cooperative agreements with states to increase capacity to prevent and respond to vector-borne diseases.
Based on historical spending for those activities, CBO estimates that implementing the legislation would cost $101 million over the 2026-2030 period, assuming appropriation of authorized amounts. The remaining $49 million would be spent after 2030.
The costs of the legislation, detailed in Table 1, fall within budget function 550 (health).
Table 1.
Estimated Increases in Spending Subject to Appropriation Under S. 2398
By Fiscal Year, Millions of Dollars
2026
2027
2028
2029
2030
2026-2030
Authorization
30
30
30
30
30
150
Estimated Outlays
6
15
23
27
30
101
The CBO staff contact for this estimate is Lea Bart. The estimate was reviewed by Chad Chirico, Director of Budget Analysis.
